title: OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.
authors.forename: Daniela D
authors.initials: DD
authors.lastname: Rosa
authors.forename: Gustavo F V
authors.initials: GF
authors.lastname: Ismael
authors.forename: Evandro
authors.initials: E
authors.lastname: de Azambuja
authors.forename: Sofia
authors.initials: S
authors.lastname: Braga
authors.forename: Fatima
authors.initials: F
authors.lastname: Cardoso
authors.forename: Harry
authors.initials: H
authors.lastname: Bleiberg
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003627:Data Interpretation, Statistical; D018572:Disease-Free Survival; D004334:Drug Administration Schedule; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D020551:Pulse Therapy, Drug; D018401:Sample Size; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D002955:Leucovorin; D005472:Fluorouracil